GNAS‐AS1 Promotes M2‐Like Macrophage Polarization, Contributing to Cervical Cancer Growth, Angiogenesis, and Metastasis Through the miR‐518c‐5p/FBXO38 Axis and MAPK Signaling
It is suggested that GNAS-AS1 may contribute to the maintenance of M2-like characteristics in TAMs and facilitate CC progression, potentially through a mechanism involving miR-518c-5p sequestering, FBXO38 upregulation, and subsequent modulation of MAPK signaling.
Abstract
The tumor microenvironment, particularly M2‐polarized tumor‐associated macrophages (TAMs), plays a critical role in cervical cancer (CC) progression. Long non‐coding RNAs (lncRNAs) are emerging as potential regulators of macrophage function. This study aimed to investigate the function and mechanism of the lncRNA GNAS‐AS1 in M2‐like TAMs and its impact on CC progression. M2 macrophages were isolated from clinical CC and adjacent normal tissues. In vitro polarization models were established using THP‐1 cells treated with PMA, LPS/IFN‐γ (M1), or IL‐4 (M2). Functional assays (CCK‐8, colony formation, Transwell) were used to assess cancer cell malignant phenotypes after co‐culture with macrophages or their supernatants. Mechanistic studies included RNA pulldown, luciferase reporter assays, and western blot. Xenograft and metastatic mouse models were employed to validate the findings in vivo. GNAS‐AS1 expression was found to be elevated in M2 TAMs isolated from CC tissues compared to other immune cells and normal tissue‐derived M2 macrophages, and its expression correlated with M2 marker levels. In vitro, GNAS‐AS1 knockdown attenuated the M2 phenotype, as evidenced by reduced expression of characteristic M2 markers and impaired ability to promote CC cell proliferation and migration. In vivo models showed that GNAS‐AS1 knockdown in M2 macrophages suppressed tumor growth and metastasis. Mechanistically, data from binding and rescue experiments are consistent with a model whereby GNAS‐AS1 may function by sequestering miR‐518c‐5p, leading to increased expression of its target, FBXO38, and associated changes in MAPK signaling. These findings suggest that GNAS‐AS1 may contribute to the maintenance of M2‐like characteristics in TAMs and facilitate CC progression, potentially through a mechanism involving miR‐518c‐5p sequestering, FBXO38 upregulation, and subsequent modulation of MAPK signaling.
Serving as a highly prevalent malignant tumor, lung adenocarcinoma (LUAD) is frequently associated with the establishment of an immunosuppressive tumor microenvironment during its initiation and progression, where M2-polarized macrophages exert pivotal effects. NCAPD3 acts as an oncogenic driver in multiple tumors; how...
Wei-Xi Zhang, Kong-Jun Zou· Korean Journal of Physiology...· 0 citations
It is indicated that FSTL1 represents a promising immunomodulatory target and highlight its potential as a therapeutic target to reprogram the immunosuppressive microenvironment and improve the efficacy of GC immunotherapy.
Ming Yang, Rong-Fei Wang, Xiao Wang et al.· Journal of Translational Med...· 0 citations
Purpose This study aimed to explore the correlation between the ability of M2-type tumor-correlated macrophage-derived exosomes (EXOs) to trigger the aggressiveness of gastric cancer (GC) cells and the miR-132-3p expression. Methods EXOs were isolated from the conditioned media of M0 and M2 macrophages and characterize...
Tao Zhang, Yong Huang, Peng Cheng et al.· Frontiers in Oncology· 0 citations
microRNA dysregulation plays a pivotal role in the tumorigenesis and metastasis of lung adenocarcinoma (LUAD). Building upon preliminary studies that identified miR-92b-3p as a potential diagnostic biomarker, this research elucidates its oncogenic mechanisms. Through the integration of cell functional assays, xenograft...
Jia-Miao Weng, Yan Lin, Ming Liu et al.· Free Radical Biology & Medic...· 0 citations
A novel mechanism by which FOXP1 transcriptionally upregulates NUSAP1 expression results in glycolytic metabolic reprogramming that induces TAM M2 polarization and promotes HCC progression, identifying a potential therapeutic avenue for reversing the immunosuppressive microenvironment in HCC.
Zhi-Wei Wang, Yu-Yi Mao, Jian-Gang Wang et al.· Frontiers in Genetics· 0 citations
To define the functional role of hsa_circ_0054391 (circ54391) in CRC progression and to evaluate its potential as a serum biomarker. Circ54391 was identified from databases and its expression was validated in CRC tissues, cell lines, and serum from healthy controls (
n
= 34), colorectal polyp patients (
n
= 3...
Cheng-Ying Xiong, Zhi-Qiang He, Xiao-Xue Liu et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.